Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
| ▸ | XBP1 | P17861 | 1/20 | 0.45 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27193249 | 0.84 | RAB9A (0.54) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL27193274 | 0.82 | PTPN1 (0.55) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL27193307 | 0.82 | MAPT (0.55) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL27193221 | 0.80 | NPC1 (0.58) | PTPN1RAB9ANPC1TRPV1SMN1; SMN2 | |
| SCHEMBL27193260 | 0.79 | MAPT (0.55) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL30828598 | 0.77 | MAPT (0.51) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL26815735 | 0.75 | NPC1 (0.59) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL27193298 | 0.74 | PTPN1 (0.61) | MAPTPTPN1RAB9ANPC1MEN1 | |
| SCHEMBL27193288 | 0.74 | ALDH1A1 (0.51) | MAPTPTPN1RAB9ANPC1KMT2A | |
| SCHEMBL24628764 | 0.72 | DEGS1 (0.57) | MAPTPTPN1RAB9ANPC1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | SAINT LOUIS UNIVERSITY (US) | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116857-A1 | QUATERNARY AMMONIUM COMPOUNDS AS ANTIMICROBIALS | ABCC1, ARG1, SLC11A2 | MAPT 3344/4885PTPN1 937/4885RAB9A 1510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.